You are here

Recarbrio

Investigation raises questions over lack of 'substantial evidence' for FDA approved antibiotic

Investigation raises questions over lack of 'substantial evidence' for FDA approved antibiotic

Medical Xpress

Flag link:

Merck secures FDA approval for Recarbrio to treat adults with HABP/VABP

Merck secures FDA approval for Recarbrio to treat adults with HABP/VABP

Pharmaceutical Business Review

hospital-acquired bacterial pneumonia

ventilator-associated bacterial pneumonia

Flag link:

FDA sets June date for latest review of Merck’s last-ditch antibiotic

FDA sets June date for latest review of Merck’s last-ditch antibiotic

Pharmaforum

Flag link:

Merck's combination antibiotic scores FDA approval for urinary tract and abdominal infections

Merck's combination antibiotic scores FDA approval for urinary tract and abdominal infections

Endpoints

intra-abdominal infections

Flag link: